How Long Does 5mg of Lexapro Stay in Your System?

A single 5 mg dose of Lexapro (escitalopram) takes roughly six to seven days to clear from your bloodstream almost entirely. That estimate comes from the drug’s elimination half-life, which studies place at about 27 to 33 hours. Because pharmacologists generally consider a drug “gone” after about five half-lives, the math works out to somewhere between five and a half and nearly seven days for a one-time low dose. But that clean number hides real variation depending on your genetics, liver function, and body composition, and the drug’s effects on your brain chemistry can outlast its measurable presence in your blood.

What the Half-Life Actually Means for a 5 mg Dose

After you swallow a 5 mg Lexapro tablet, the drug is absorbed relatively fast, reaching its peak concentration in your blood within about three to four hours. From that peak, escitalopram is gradually broken down and removed. The rate of removal is described by the half-life: the time it takes for the amount of drug in your blood to drop by half. For escitalopram, that half-life averages 27 to 33 hours across studies of healthy adults receiving single and repeated doses.¹²

So if you take 5 mg and your personal half-life is 30 hours, after 30 hours roughly 2.5 mg worth of the drug remains in circulation. After another 30 hours, about 1.25 mg remains, and so on. By the time five half-lives have passed (around 150 hours, or about six days), less than 0.2 mg remains. That trace amount is generally considered pharmacologically negligible, meaning it is too small to produce any meaningful effect. If your half-life sits closer to 33 hours, the timeline stretches to about seven days. If it is closer to 27, clearance might wrap up in under six days.

One important distinction: 5 mg is the lowest standard dose of Lexapro, often used as a starting dose or as a maintenance dose for people who respond well to it. Because the starting amount is small, the absolute quantity lingering at each half-life step is lower than it would be at 10 or 20 mg. The drug does not leave your body any faster at a lower dose, but the point at which the remaining amount becomes trivially small arrives sooner simply because there was less drug to begin with.

Your Genetics Can Shift the Timeline Significantly

Escitalopram is broken down in your liver primarily by an enzyme called CYP2C19, with smaller contributions from two other enzymes, CYP2D6 and CYP3A4.³⁴ The gene that codes for CYP2C19 varies quite a bit from person to person. Some people have versions that make a highly active enzyme (these individuals are sometimes called ultrarapid metabolizers), while others carry versions that produce a sluggish or barely functional enzyme (poor metabolizers). Most people fall somewhere in the middle as normal metabolizers.

The practical difference is not small. A pharmacokinetic modeling study found that for escitalopram specifically, a poor metabolizer would need only 10 mg per day to reach the same blood levels that a normal metabolizer gets from 20 mg, while an ultrarapid metabolizer would need 30 mg per day to match that same exposure.⁵ That threefold spread in dose equivalence tells you that the drug hangs around much longer in poor metabolizers and clears much faster in ultrarapid ones. If you are a poor metabolizer and take 5 mg of Lexapro, the drug may linger meaningfully for over a week. If you are an ultrarapid metabolizer, your body might clear it in four or five days.

You would not necessarily know which category you fall into without pharmacogenomic testing. Roughly two to three percent of people of European descent are poor metabolizers of CYP2C19, but that proportion varies across populations. If you have ever noticed that a standard medication dose seemed unusually strong or unusually weak, your CYP2C19 status could be a contributing factor.

Liver Health, Body Size, and Age

Because escitalopram is processed almost entirely by the liver, anything that impairs liver function can slow elimination. A review of antidepressant pharmacokinetics in people with liver disease found that dose adjustments are important for most antidepressants in these patients, since the drugs are predominantly metabolized by the liver and many carry dose-dependent side effects.⁶ For someone with significant liver impairment, a 5 mg dose of Lexapro could stick around considerably longer than the standard six-to-seven-day estimate, and prescribers often recommend half the usual dose in these patients for that reason.

Body composition also plays a role. A population pharmacokinetic study found that body weight affected how quickly escitalopram was cleared, and body mass index influenced the drug’s volume of distribution, which is a measure of how widely the drug spreads through your tissues.⁷ Escitalopram is lipophilic, meaning it dissolves readily into fatty tissue. A person with a higher proportion of body fat may have a larger reservoir of tissue where the drug can accumulate, potentially extending the tail end of elimination.

Age, interestingly, may matter less than you would expect. A study comparing healthy elderly individuals with younger adults after a single oral dose of escitalopram found that the pharmacokinetic profiles were quite similar between the two groups, with nearly identical peak concentrations and overall drug exposure.⁸ That said, healthy elderly volunteers may not represent the general older population, many of whom take multiple medications or have some degree of liver or kidney change. In practice, age often correlates with other factors that do slow clearance, even if age alone does not dramatically change the half-life.

Why the Brain Effects Outlast the Blood Levels

Here is where the question “how long does it stay in your system” gets more complicated than a simple half-life calculation can answer. Escitalopram works by blocking the serotonin transporter (often abbreviated SERT) in your brain, which is the protein that normally vacuums serotonin back into the nerve cell that released it. When the transporter is blocked, more serotonin stays available in the spaces between neurons.

A systematic review looking at the relationship between antidepressant dose and serotonin transporter occupancy found that for escitalopram, the occupancy of these transporters decreased at a slower rate than the drug’s plasma concentration.⁹ In other words, even after blood levels have dropped substantially, the drug is still clinging to its targets in the brain. This lag means the functional effects of Lexapro persist beyond what a blood test would suggest. If you are wondering how long the drug is “doing something” rather than merely “detectable,” the answer is probably a day or two longer than the plasma clearance timeline.

This disconnect between blood levels and brain activity also matters during tapering. When someone stops taking Lexapro, the serotonin system does not snap back to its pre-drug state the moment the last molecule clears the blood. Serotonin transporter density itself changes during chronic treatment, and those changes take days to weeks to normalize. For someone on only 5 mg, this adjustment period is generally milder than for someone coming off a higher dose, but it still exists.

Single Dose Versus Steady State

The six-to-seven-day estimate applies cleanly to a single, isolated 5 mg dose. If you have been taking 5 mg of Lexapro daily for weeks or months, the situation is different. With daily dosing, each new dose arrives before the previous one has fully cleared, and the drug accumulates to a stable plateau called steady state. Research indicates that escitalopram reaches steady state within about seven to ten days of consistent daily dosing.²¹⁰

At steady state, your body contains more total escitalopram than a single dose would produce, because the residuals from previous days’ doses are stacked on top of each other. When you stop taking the drug after reaching steady state, the starting point for elimination is higher, so it takes longer for the drug to become undetectable. Instead of six or seven days from the last pill, you might be looking at seven to nine days or a bit more, depending on your individual metabolism. The half-life itself does not change, but the total amount that needs to be cleared is greater.

Drug Testing and Detection

Lexapro is not one of the substances screened for on standard workplace or military drug panels. Those tests typically look for drugs of abuse like amphetamines, opioids, cannabis, cocaine, and benzodiazepines. Escitalopram does not fall into any of those categories, and it does not structurally resemble them closely enough to trigger a false positive on immunoassay screens.

That said, escitalopram can be detected by specialized laboratory methods designed to identify antidepressants specifically. One validated analytical technique was able to detect escitalopram in human urine at concentrations as low as about 7 ng/mL, with quantification starting at 25 ng/mL.¹¹ These specialized tests might be ordered in clinical toxicology, forensic, or research settings. For everyday purposes, though, taking Lexapro will not show up on a routine drug screen, and there is no reason to worry about failing a pre-employment test because of it.

In urine, metabolites of escitalopram can potentially linger a bit longer than the parent drug in blood, because the kidneys continue excreting breakdown products after plasma levels have dropped. The precise urine detection window for a 5 mg dose has not been nailed down in a published study specific to that dose level, but given the low starting amount, detectable traces in urine would likely be gone within a week or so of the last dose for most people.

Drug Interactions and Clearance Speed

If you take other medications alongside Lexapro, the clearance timeline could shift. Any drug that inhibits CYP2C19, the primary enzyme responsible for breaking down escitalopram, will slow elimination and effectively extend how long the drug stays in your body. Common CYP2C19 inhibitors include certain acid-reflux medications like omeprazole, some antifungals, and a few other antidepressants.

On the flip side, escitalopram itself is unlikely to affect how quickly your body processes other drugs you are taking. A review of drug interactions with second-generation antidepressants found that escitalopram is a weak or negligible inhibitor of the major liver enzymes that handle drug metabolism, making it less likely than many other antidepressants to cause problematic interactions with co-administered medications.¹² This is one of the practical advantages of escitalopram over some older antidepressants, particularly for people who take multiple medications.

Transfer Through Breast Milk

For nursing parents, the question of how long Lexapro stays in your system extends to how much of it reaches your infant. A population pharmacokinetic study of escitalopram in women during the perinatal period found that, on average, the milk-to-plasma ratio was about 1.9, meaning the drug concentrated somewhat in breast milk compared to blood. Simulations from that study estimated that an exclusively breastfed infant would ingest roughly 3.3 percent of the mother’s weight-adjusted dose each day through breast milk.¹³ Milk fat content also mattered: when the fat content of the milk doubled, drug transfer increased by about 28 percent for escitalopram.

At a maternal dose of 5 mg, the absolute amount reaching the infant would be very small. Still, because infants have immature liver enzyme systems and cannot clear the drug as efficiently as an adult, even small amounts are worth discussing with a pediatrician. The drug’s presence in breast milk follows the same general half-life kinetics as in the mother’s blood, so after the mother stops taking Lexapro, drug levels in milk would decline over the same six-to-seven-day trajectory, with a lag of several hours behind plasma levels.

Tapering Off 5 mg

Because 5 mg is already the lowest standard dose, some people and prescribers assume it is safe to stop abruptly without tapering. For many people at this dose, that turns out to be fine. But it is not universally true. The brain adapts to the presence of the drug over time, and even at 5 mg, some people experience discontinuation symptoms like dizziness, irritability, “brain zaps” (brief electric-shock sensations), or sleep disturbance when they stop suddenly.

The finding that serotonin transporter occupancy declines more slowly than blood levels helps explain why discontinuation symptoms can appear even after the drug seems like it should be “out of your system.”⁹ The brain’s serotonin machinery needs time to recalibrate. For people who are sensitive to this transition, prescribers sometimes suggest cutting the 5 mg tablet in half for a week or two before stopping entirely, or switching to every-other-day dosing briefly. There is no one-size-fits-all protocol, but the principle is to give the brain a gentler off-ramp.

If you have been on 5 mg for only a few weeks, the odds of meaningful discontinuation symptoms are lower than if you have been taking it for months or years, because the degree of neuroadaptation generally increases with duration of use. Either way, the physical presence of escitalopram in your blood will follow the same half-life math. It is the brain’s adjustment period, not the drug’s elimination, that determines how long you feel the transition.